Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cassava Sciences Inc (SAVA)

Cassava Sciences Inc (SAVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 105,795
  • Shares Outstanding, K 48,308
  • Annual Sales, $ 0 K
  • Annual Income, $ -24,340 K
  • EBIT $ -146 M
  • EBITDA $ -145 M
  • 60-Month Beta -2.04
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.79

Options Overview Details

View History
  • Implied Volatility 104.14% ( -0.74%)
  • Historical Volatility 55.90%
  • IV Percentile 32%
  • IV Rank 6.20%
  • IV High 753.77% on 04/09/25
  • IV Low 61.21% on 07/03/25
  • Put/Call Vol Ratio 0.02
  • Today's Volume 639
  • Volume Avg (30-Day) 1,315
  • Put/Call OI Ratio 0.18
  • Today's Open Interest 66,318
  • Open Int (30-Day) 70,271

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Sell
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -1.28
  • Growth Rate Est. (year over year) +78,146.88%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.75 +23.43%
on 06/27/25
2.23 -3.14%
on 07/09/25
-0.01 (-0.46%)
since 06/10/25
3-Month
1.21 +78.51%
on 04/11/25
2.32 -6.70%
on 05/16/25
+0.97 (+81.51%)
since 04/10/25
52-Week
1.15 +87.83%
on 04/10/25
42.20 -94.88%
on 08/05/24
-9.00 (-80.65%)
since 07/10/24

Most Recent Stories

More News
Cassava Presents Promising Preclinical Simufilam Data at TSC Alliance Meeting

SAVA : 2.16 (-1.37%)
Cassava Reports Q1 2025 Financials Results, Provides Business Update

SAVA : 2.16 (-1.37%)
Cassava Appoints Angélique Bordey, PhD, to Enhance Preclinical Program in TSC

SAVA : 2.16 (-1.37%)
Cassava Announces Retirement of Chief Medical Officer, Dr. Jim Kupiec, and Appointment of Dr. Jack Moore as Senior Vice President, Clinical Development

SAVA : 2.16 (-1.37%)
Cassava Sciences Stock Drops Over 30% After Alzheimer’s Drug Fails Study – But Retail Remains Hopeful

The drug showed no treatment benefit for patients in the study called REFOCUS-ALZ, the company said, while adding that the Alzheimer’s disease development program with Simufilam will be discontinued...

VTI : 308.32 (+0.27%)
IWM : 224.80 (+0.51%)
SAVA : 2.16 (-1.37%)
Cassava Sciences Reports Topline Phase 3 REFOCUS-ALZ Data

SAVA : 2.16 (-1.37%)
Cassava Sciences Reports 2024 Financial Results and Provides Business Update

SAVA : 2.16 (-1.37%)
Cassava Sciences Licenses Simufilam Method of Treatment Patent

SAVA : 2.16 (-1.37%)
Cassava Sciences Provides a Business Update

SAVA : 2.16 (-1.37%)
Contact Levi & Korsinsky by February 10, 2025 Deadline to Join Class Action Against Cassava Sciences, Inc. (SAVA)

New York, New York--(Newsfile Corp. - January 2, 2025) - Levi & Korsinsky, LLP notifies investors in Cassava Sciences, Inc. ("Cassava Sciences, Inc." or the "Company") (NASDAQ: SAVA) of a class action...

SAVA : 2.16 (-1.37%)

Business Summary

Cassava Sciences Inc. is focused on the early detection and treatment of neurodegenerative diseases, such as Alzheimer's. Cassava Sciences Inc., formerly known as Pain Therapeutics Inc., is based in Austin, United States.

See More

Key Turning Points

3rd Resistance Point 2.28
2nd Resistance Point 2.25
1st Resistance Point 2.20
Last Price 2.16
1st Support Level 2.12
2nd Support Level 2.09
3rd Support Level 2.04

See More

52-Week High 42.20
Fibonacci 61.8% 26.52
Fibonacci 50% 21.68
Fibonacci 38.2% 16.83
Last Price 2.16
52-Week Low 1.15

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar